Yes I think that it is unlikely to be above the current market price, unless what effectively happens is that there is a takeover by another interested larger company.
I doubt that the management team is interested in a takeover, but this is a real possibility, when the company is undervalued !!!
I predict a few institutional investors coming in for $3m at 3c a share just to see the company into the July September zone. Or a takeover.
They will be shown the preliminary data from the CPN trial? They may even have greater access to the preliminary data from the smoking cessation trial? And any data from NIMA study
IVX Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)